Subnavigation

• Influenza
• Surveillance and monitoring
  • Updates
  • FluID
• GISRS and laboratory
  • FluNet
  • National Influenza Centres
  • WHO Collaborating Centres for influenza and Essential Regulatory Laboratories
  • WHO H5 Reference Laboratories
  • Antiviral susceptibility surveillance
  • WHO External Quality Assessment Project
  • Shipping and logistic activities
• PIP Framework
  • Advisory Group
  • Virus Sharing
  • Benefit Sharing
• Vaccines
  • Vaccine viruses
  • Vaccine use
• Patient care
  • Clinical management
  • Antivirals
• Human animal interface
  • Avian influenza in humans
  • Swine influenza in humans
• Public health preparedness
• Information resources
  • Research
  • Training
  • Publications

Virology laboratories and vaccines

• Antigenic and genetic characteristics of A(H5N1), A(H7N3), A(H9N2) and variant influenza viruses and candidate vaccine viruses developed for potential use in human vaccines
  February 2013
• WHO reference laboratories for diagnosis of influenza A/H5 infection
  19 June 2009
• Availability of a new recombinant A(H5N1) vaccine virus
  03 August 2010
• Availability of a new recombinant A(H5N1) vaccine virus
  July 2010
• Availability of a new recombinant H5N1 vaccine virus
  June 2010
• Candidate vaccine viruses and potency testing reagents for influenza A(H5N1)
  June 2010
• WHO guidelines for the storage and transport of human and animal specimens for laboratory diagnosis of suspected avian influenza A infection
  June 2009
• Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses
  March 2009
• A description of the process of seasonal and H5N1 influenza vaccine virus selection and development
  Draft 19 November 2007
• Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases
  August 2007
• WHO laboratory biosafety guidelines for handling specimens suspected of containing avian influenza A virus
  January 2005

Additional information

• Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection.
  Guide for field operations
  October 2006
• Laboratory study of H5N1 viruses in domestic ducks: main findings
  29 October 2004
• WHO/ISIRV/FIND Consultation on Diagnosis of H5N1 Avian Influenza Infections in Humans
  19-20 February 2007
• WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection
  12 January 2005
• Guidelines for the use of seasonal influenza vaccine in humans at risk of H5N1 infection
  30 January 2004
• A description of the process of seasonal and H5N1 influenza vaccine virus selection and development
  19 November 2007
• Joint WHO/OIE/FAO consultation on the feasibility of producing human vaccines in veterinary vaccine facilities
  pdf, 32kb
• WHO procedures for obtaining release of H5N1 sequences to the public domain
  23 August 2006
• A summary of tracking avian influenza A(H5N1) specimens and viruses shared with WHO from 2003 to 2007
• A summary of tracking avian influenza A(H5N1) specimens and viruses shared with WHO from 2003 to 2007
  pdf, 22kb
  31 January 2008
• Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment.
  pdf, 489kb
  November 2003